Parathyroid cancer is very rare. Most cases of parathyroid disease, including almost all cases of overactive parathyroid, are not cancer. At Fred Hutchinson Cancer Center, our endocrine tumor ...

Parathyroid cancer is a cancerous (malignant) growth in a parathyroid gland. This cancer form is usually associated with high blood calcium levels. Once your doctor confirms that you have parathyroid ...

September 19, 2007--Cinacalcet ( Sensipar, Amgen) may emerge as an important new therapeutic option for patients with inoperable parathyroid carcinoma, researchers report. According to the results of ...

A newly-created prognostic tool reliably predicts the recurrence of parathyroid cancer, enabling physicians to identify patients at the highest risk. Consequently, the tool also helps to determine the ...

New research reveals that the drug cinacalcet HCl (cinacalcet) may effectively reduce the dangerous accumulation of calcium in the blood that typically accompanies parathyroid cancer. This drug ...

Phase I dose escalation study of pan-histone deacetylase (HDAC) inhibitor abexinostat in combination with cisplatin in patients with advanced non-keratinizing nasopharyngeal carcinoma. E1308: ...

Parathyroid hormone-related peptide is a regulatory protein implicated in the pathogenesis of bone metastases, particularly in breast carcinoma. Parathyroid hormone-related peptide is widely expressed ...

Parathyroid hormone-related protein (PTHRP) was first identified as the causative factor in the paraneoplastic syndrome humoral hypercalcaemia of malignancy (HHM) (Suva et al, 1987). The ...

Parathyroid cancer is the cancer of the parathyroid glands (small glands located in the neck or upper mediastinum). The cancerous cells disrupt the primary function of the glands, which is to make ...

You are at the center of everything we do at Fred Hutch Cancer Center. Here, we surround you with a team of specialists from the Fred Hutch Endocrine Tumor Clinic and UW Medical Center Endocrine ...